Ivectosol (human grade solubilized ivermectin) / Mountain Valley - LARVOL DELTA

Physical and pharmacokinetic characterization of Soluvec™, a novel, solvent-free aqueous ivermectin formulation. (PubMed, Ther Deliv) - "SC and IM Soluvec increased IVM exposure, peak IVM and extended duration of IVM exposure, versus oral dosing. The Quicksol method generated Soluvec, a concentrated aqueous parenteral IVM formulation with pharmacokinetic properties suitable for veterinary or human use."

Journal • PK/PD data

Grand Rounds July 8: Results From the COVID-OUT Trial, a Phase-3 trial of Outpatient Treatment for Covid-19 Using Metformin, Ivermectin, and Fluvoxamine (NIH Pragmatic Trials Collaboratory)

Grand rounds • Novel Coronavirus Disease

Ivermectin & Aducanumab: Do They Work? (w/Dr. Vinay Prasad) (YouTube) - "Two doctors analyze the evidence so far on ivermectin for COVID-19 and Aduhelm (aducanumab) for Alzheimer's."

Video

Mountain Valley MD Receives Successful Results From BSL-4 COVID-19 Clearance Trial on Three Variants Tested With Ivectosol (GlobeNewswire) - "Mountain Valley MD Holdings Inc....has received its third-party Bio Safety Level 4 ('BSL-4') lab study results from its recent COVID-19 viral clearance study conducted with its solubilized Ivermectin technology - Ivectosol....Tests done in vitro showed the same antiviral effect at 5uM Ivectosol™ concentration after 24 hours and again after 48 hours against all three COVID-19 variants tested - the original B.1.1.7 variant, the South African B.1.351 variant, and the P.1 Brazil variant....The Company will immediately pursue a combined pharmacokinetic and phase one human trial to verify the efficacy of Ivectosol™ sublingual wafers in COVID-19 infected patients. The new human studies are anticipated to include the 'triple-mutant India variant' B.1.617...The Company’s patented Quicksol™ solubilized Ivermectin offered superior pharmacokinetic performance across every single measure conducted, with no adverse side effects using up to 1/8th of the Ivermectin drug..."

Preclinical • Infectious Disease • Novel Coronavirus Disease